Stax logo

Managing ESG Risk in Healthcare

Managing ESG Risk in Healthcare

Anuj A. Shah & Rob Larson • October 12, 2023
Anuj A. Shah & Rob Larson • October 12, 2023

Share

In the healthcare sector, the industry’s core mission revolves around enhancing and preserving lives, which can lead organizations to encounter a multifaceted array of Environmental, Social, and Governance (ESG) challenges. While these challenges are diverse and extend beyond the scope of this introduction, it's essential to identify, comprehend, and effectively manage them within a strategic ESG due diligence framework.

 

By taking a proactive approach to addressing ESG risks, organizations can ensure the delivery of equitable care, safeguarding of patient data, adherence to ethical business practices, and promotion of inclusivity in clinical trials. This comprehensive strategy not only ensures compliance but may also generate substantial value in a critical sector.

Identifying ESG Risks 

Within the healthcare industry, numerous pivotal ESG risks have been discerned; each serving as a fundamental catalyst in molding the future industry landscape. These risks form the core of our ESG due diligence framework and facilitate a comprehensive evaluation specific to an individual asset. Below, we delve into a select few key ESG risks within the domain:

Access to Care

Organizations delivering care or manufacturing medicines are under pressure to offer equitable access to care. They face reputational risks if they ignore the impact on groups of patients who are unequally afforded access to care. Ensuring access to quality healthcare for all is not only an ethical imperative but also a strategic necessity.

Patient Data Security

Patient data security is a direct risk for organizations that handle or protect patient data, including those involved in developing precision medicine. Safeguarding patient information is paramount not only to comply with regulations but also to maintain trust and confidence in healthcare services.

Business Ethics

Fee-for-service reimbursement models may incentivize health organizations to deliver more care than is medically necessary. This exposes them to regulatory and public scrutiny if ethical business practices are abused. Upholding the highest ethical standards in healthcare delivery is vital for maintaining public trust. 

Diversity & Inclusion in Clinical Trials

Companies developing medicines face growing public pressure to include a diverse and representative patient mix in clinical research trials. Ensuring diversity in clinical trials not only enhances the validity of research but also contributes to addressing healthcare disparities among different demographic groups.

ESG Due Diligence Process 

Stax’s ESG due diligence process involves a thorough assessment of material ESG risks across industries. We go beyond identification and provide strategic recommendations on how to track, monitor, and minimize risks during the ownership period. By implementing recommendations, organizations can ensure they are on the right path to meeting asset-specific ESG goals and responsibilities.


By proactively addressing ESG risks, organizations in the healthcare sector can enhance their reputations, strengthen patient trust, and contribute to the overall well-being of society. As the healthcare landscape evolves, it will become increasingly essential for organizations to embed ESG strategies into their operations, ensuring both patients and the healthcare ecosystem as a whole benefit. 

Image of Anuj A. Shah

Managing Director | ESG & Impact Advisory

Image of Rob Larson

Director | Healthcare

Read More

Feat. by International Policy Digest: US Tariffs & PE Strategies
April 1, 2025
Brad Kuntz sat down with International Policy Digest to discuss how private equity firms are adapting to trade disruptions and economic uncertainty. Click here to read the full interview.
Global Decarbonization Trends: What PE Investors Need to Know
By Anuj A. Shah, Brad Kuntz, Joel Slater March 24, 2025
With rising demand for electrification, net-zero commitments, and state-level climate policies, Anuj A. Shah, Brad Kuntz, and Joel Slater share how PE investors can capitalize on this growth.
Stax Advises HITRUST on Growth Investment from Brighton
March 19, 2025
Stax recently supported HITRUST, a leader in information security assurance for risk and management and compliance, on its growth investment by Brighton Park Capital. Learn more.
Stax Advises Quorum Software on its Acquisition of zdSCADA
March 17, 2025
Stax recently supported Quorum Software on its acquisition of zdSCADA, a leader in cloud-based supervisory control and data acquisition (SCADA) technology. Read more here.
Stax Advises Audax on its Strategic Investment in Fortis
March 17, 2025
Stax recently supported Audax Private Equity on its strategic investment in Fortis, a leading payments technology for software providers, ERP customers, & scaling businesses. Read more.
De-Globalization & Strategic Risks: Safeguard and Unlock Value
By Anuj A. Shah March 14, 2025
Tariffs, de-globalization, trade barriers, and ESG mandates are reshaping strategies. Anuj A. Shah shares how Stax’s holistic framework helps PE firms navigate these shifts. Learn more.
Show More
Share by: